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Neurexins are presynaptic transmembrane proteins that play an essential role in synapse function. The
crystal structures of aneurexin extracellular domains (Chen et al., 2011; Miller et al., 2011) provide important
insights into their conformational freedom and their putative spatial arrangement with binding partners in the
synaptic cleft.In twoclosely relatedpapers in this issueof
Structure, the groups of Gabby Rudenko,
Meghan Miller, and Palmer Taylor present
crystal data of most of the extracellular
sequences of aneurexins (Chen et al.,
2011; Miller et al., 2011). Neurexins form
an important family of presynaptic orga-
nizer molecules at the neuronal synapse
that have also been linked to autism and
schizophrenia (Su¨dhof, 2008). Three neu-
rexin genes exist in vertebrates (NRXN1-
3), each of which comes in two flavors:
longer aneurexins that consist of six
laminin A, neurexin, and sex hormone-
binding protein (LNS1-6) domains inter-
spersed by three EGF-like domains; and
shorter bneurexins that lack all but the
last LNS domain, which is identical
between aneurexins and bneurexins
(Missler and Su¨dhof, 1998). While addi-
tional alternative splicing occurs at five
distinct sites (SS1-5) in the extracellular
sequence of neurexins, the presence or
absence of a single insert at SS4 in the
LNS6 domain shared between the two
major transcripts initially attracted the
most attention because it appears to regu-
late binding to postsynaptic neuroligins
(Missler and Su¨dhof, 1998; Su¨dhof, 2008).
These back-to-back papers on the
complex domain chain of aneurexins
represent a remarkable achievement
because the neurexin 1a chain length
solved ranks among the top 30 of the
largest proteins, made even more chal-
lenging by its extended structure with no
local symmetry. Missing from the data
sets are only the N-terminal 320 residues
of the protein that contain the first LNS
and EGF domains (LNS1-EGF1) because
they are likely flexible, as shown recently
by single-particle EM and low-resolution
X-ray scattering (Comoletti et al., 2010).
Chen et al. (2011) included the N-terminal
LNS1-EGF1 fragment in the crystal butdid not obtain reliable data on this region,
whereas Miller et al. (2011) deleted the
fragment from the beginning.
Although all three structures presented
by the two studies (i.e., neurexin 1a with
and without Ca2+, and with and without
splice insert at SS3) are remarkably
similar (PDB: 3R05, 3QCW, and 3POY),
the two papers highlight different aspects
of the molecule and therefore comple-
ment each other very well; each of the
five LNS domains crystallized here con-
tain an identically folded core, but indi-
vidual surface loops give each domain
a putatively unique functionality (Miller
et al., 2011). Although the LNS and EGF
domains can be organized into cassettes
based on the primary sequence (Missler
and Su¨dhof, 1998), the authors’ data
now reveal that the overall structure of
neurexin 1a in fact contains no repetitive
structural units. Rather, each LNS-EGF-
LNS or LNS-LNS unit is individually
arranged, and the LNS dimers represent
new units that do not match the
conserved dimers found in laminin or
Gas6, which were used as structural
analogs, e.g., for the binding to dystrogly-
can. The new analysis of the LNS3-EGF2-
LNS4 unit in aneurexin is particularly
surprising because it reveals a reelin-like
domain arrangement (Chen et al., 2011),
a protein domain involved in neuron
migration, which will likely prompt investi-
gations whether neurexins are also
involved in this process. In addition, all
known calcium binding sites of LNS2 to
LNS5 face to one side of the molecule, re-
sulting in a putative regulation of the
calcium coordination site of LNS4 by
intermolecular contacts to LNS3.
Perhaps the most interesting aspect
of the new structures is that it allows
some predictions on the conformational
arrangement of aneurexin in the synap-Structure 19, June 8, 2011tic cleft and on its ability to form trans-
synaptic complexes with functionally
important binding partners such as neuro-
ligin (Nlgn), postsynaptic molecules with
esterase-like extracellular domains that
are also spliced at two positions (denoted
A and B). First, the extracellular domain
of aneurexin apparently exists in an
‘‘open’’ L-shaped form, exposing the
LNS6 domain to bind to Nlgn similar to
the known neurexin 1b/Nlgn complex
(the LNS6 domain in a and bneurexin
is shown in red in Figure 1). Both groups
present a neurexin 1a /Nlgn1 complex
model in which the Nlgn splice insert A
comes in steric contact with the LNS4
domain and with the aneurexin splice
insert at SS3, if it is present (grey shadow
structure with black contour in Figure 1).
The finding that splice insert A of neuroli-
gin can regulate its binding to neurexin
1a (in addition to the previously known
role of splice insert B) represents a high-
light of both studies. Secondly, both
groups also show that the complex
formation requires a flexible hinge
between LNS5 and EGF3 that allows
displacement of the tightly packed unit
consisting of LNS2 to LNS5 from the
EGF3-LNS6 unit (large arrow in Figure 1).
This finding validates existing biochem-
ical data that the isolated LNS6 domain
behaves differently compared with the
LNS5-EGF3-LNS6 unit (Reissner et al.,
2008; Tanaka et al., 2011) or to full-length
neurexin 1a, as LNS6+SS4 binds to Nlgn
with splice insert B (Nlgn+B) (Koehnke
et al., 2010) but neurexin 1a+SS4 does
not (Miller et al., 2011), suggesting that
an insert at SS4 will change the orienta-
tion of the EGF3-LNS6 unit at the hinge
to a ‘‘closed’’ form that inhibits binding
to Nlgn+B. Third, based on the current
structures and previous data, it appears
that the regulation of neurexin 1a bindingª2011 Elsevier Ltd All rights reserved 749
Figure 1. Dynamic Orientation of Neurexin 1a within the Synaptic Cleft
Shown here is a structural model of presynaptic neurexin 1a and neurexin 1b simultaneously binding to
a postsynaptic neuroligin dimer (see graphical legend for identification of different synaptic components).
According to the new crystal structures, neurexin 1a binds neuroligin in an unexpected orientation (gray
shadow structure with black contour) that faces back to the presynaptic site (Chen et al., 2011; Miller
et al., 2011). The presence of splice insert A in neuroligin that would interfere with this orientation or binding
of additional interaction partners to aneurexin might lead to a reorientation of the rigid LNS2-LNS3-
LNS4-LNS5 unit within the synaptic cleft (black arrow indicates one of several possible directions). The
flexibility in the neurexin 1a molecule is made possible by two hinge regions indicated by the curved
arrows (magenta) in the space-filling model at the lower right of the diagram, in which different colors iden-
tify the LNS1-6 domains for easier recognition of their arrangement. Note that the LNS6 domain of
aneurexin is shared by the corresponding bneurexin (red in both molecules), leading to the possibility
of mixed complexes with an individual neuroligin dimer.
Structure
Previewsto neuroligin by alternative splicing is
more complex than initially thought. For
neurexin 1b, several structures are
available that contain or lack the insert
at SS4, which propose that there is
a temporal switch from an inactive (PDB:
2R1B) to an active form (PDB: 3MW2)
that will bind to any neuroligin variant,
albeit with a different affinity if the Nlgn
splice insert B is present. Neurexin 1a
binding to Nlgn, in turn, is dependent on
the presence of the splice inserts A and
B in neuroligin and is further regulated
by the temporal switch provided by
splice insert SS4 in the neurexin LNS6
domain. Although additional biochemical
studies are required, the current struc-
tures indicate that, due to the rigid asym-
metric arrangement of domains and the750 Structure 19, June 8, 2011 ª2011 Elseviepresence of only two major hinges in the
entire extracellular domain (Figure 1),
each binding partner will likely influence
the binding of additional partners by reor-
ientation of the LNS2-to-LNS5 unit within
the synaptic cleft.
The transsynaptic complex between
neurexins and neuroligins plays an essen-
tial role in synapse function in the nervous
system because they effect synaptic
transmission and the formation of
contacts (Su¨dhof, 2008). The availability
of comparable structures of individual
a and bneurexins and their domains
(e.g., Chen et al., 2011; Miller et al.,
2011; Sheckler et al., 2006; Shen et al.,
2008), along with those of the actual inter-
action site in the bneurexin/neuroligin
complex (Arac¸ et al., 2007; Chen et al.,r Ltd All rights reserved2008; Fabrichny et al., 2007; Reissner
et al., 2008), makes these synaptic cell-
adhesion molecules some of the structur-
ally best-characterized neuronal proteins.
There is little doubt that the two new
papers discussed here will push research
into the function of synaptic cleft proteins
and their precise macromolecular organi-
zation to the next level. In any case,
their efforts have dealt a death blow to
the still omnipresent illustration of the
neurexin/neuroligin complex as ‘‘antipar-
allel sticks‘‘.
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